Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.17 trillion and total revenue of $111.73 billion.
Market Cap
1.17T
Revenue
111.73B
Profits
-39.4B
PE Ratio
n/a
Profit Margin
-35.26%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.45B | 0.69% | 638,718 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 73.65B | 3.09% | 402,872 | 14.92B |
| 3 | ARGX | argenx SE | 50.31B | 1.04% | 258,543 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.59B | 0.97% | 519,361 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.77B | 5.16% | 296,751 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 32.10B | 2.57% | 1,110,408 | - |
| 7 | RPRX | Royalty Pharma plc | 30.10B | 0.66% | 2,039,521 | 2.44B |
| 8 | INSM | Insmed Incorporated | 29.85B | -0.81% | 1,156,129 | 606.42M |
| 9 | BNTX | BioNTech SE | 23.93B | -0.93% | 689,712 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.50B | 1.15% | 1,727,154 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.96B | 2.49% | 432,225 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 19.41B | 4.73% | 2,990,850 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.09B | 1.42% | 1,105,133 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.39B | 3.37% | 499,463 | 845.52M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.17B | 6.43% | 1,487,473 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.81B | 1.43% | 2,336,222 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.42B | -0.38% | 1,606,390 | 502.08M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.73B | 2.34% | 870,873 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.31B | 6.78% | 423,297 | 1.13B |
| 20 | EXEL | Exelixis, Inc. | 12.29B | 8.91% | 4,146,334 | 2.38B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.41B | -0.56% | 374,637 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.05B | 5.35% | 944,171 | 1.09B |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | 2.51% | 1,439,246 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.78B | 2.16% | 1,047,457 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.38B | -2.19% | 3,179,117 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.37B | 0.98% | 209,316 | 7.46M |
| 27 | IBRX | ImmunityBio, Inc. | 8.52B | 8.84% | 16,668,846 | 113.29M |
| 28 | KRYS | Krystal Biotech, Inc. | 8.45B | 0.73% | 174,035 | 417.30M |
| 29 | PCVX | Vaxcyte, Inc. | 8.18B | 1.85% | 987,302 | - |
| 30 | NUVL | Nuvalent, Inc. | 8.13B | 1.96% | 188,074 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.95B | 1.82% | 522,307 | 1.40B |
| 32 | TECH | Bio-Techne Corporation | 7.36B | -16.97% | 8,625,315 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.08B | 4.07% | 245,327 | 51.48M |
| 34 | CELC | Celcuity Inc. | 6.69B | -2.39% | 592,148 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.63B | 3.98% | 403,467 | 74.06M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.60B | 4.39% | 947,425 | 217.17M |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | 1.52% | 513,645 | 521.31M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.33B | 2.61% | 389,263 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.32B | 1.57% | 245,122 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.04% | 531,588 | 15.00M |
| 41 | TGTX | TG Therapeutics, Inc. | 6.13B | 14.96% | 5,188,888 | 700.35M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.12B | -3.24% | 959,046 | - |
| 43 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.04% | 6,347,046 | - |
| 44 | BLTE | Belite Bio, Inc | 6.09B | 0.33% | 155,160 | - |
| 45 | CGON | CG Oncology, Inc. | 5.92B | 0.22% | 268,531 | 4.04M |
| 46 | IMVT | Immunovant, Inc. | 5.78B | 1.94% | 818,305 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.69B | 1.18% | 512,088 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.66B | 1.43% | 293,388 | 7.50M |
| 49 | CORT | Corcept Therapeutics Incorporated | 5.66B | 2.65% | 679,867 | 769.10M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.50B | 2.08% | 276,557 | 1.73B |
| 51 | LEGN | Legend Biotech Corporation | 5.40B | 2.46% | 2,459,474 | 1.03B |
| 52 | CAI | Caris Life Sciences, Inc. | 5.40B | 0.84% | 1,016,994 | 812.03M |
| 53 | CRSP | CRISPR Therapeutics AG | 5.30B | 4.81% | 1,379,610 | 4.10M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.07% | 2,506,862 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -0.46% | 322,927 | 1.34M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | -0.90% | 83,942 | 268.09M |
| 57 | MANE | Veradermics, Incorporated | 4.46B | -5.63% | 621,072 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.40B | 3.02% | 761,942 | 7.70M |
| 59 | ORKA | Oruka Therapeutics, Inc. | 4.18B | 1.16% | 1,217,578 | - |
| 60 | TVTX | Travere Therapeutics, Inc. | 4.14B | -0.62% | 1,542,615 | 536.20M |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 3.96B | -3.00% | 1,798,105 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.79B | -0.85% | 1,377,556 | 1.07B |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.73B | 0.91% | 60,324 | 803.79M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.72B | 2.43% | 1,712,873 | - |
| 65 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.72B | -1.26% | 1,100,347 | 588.99M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.56B | 3.72% | 510,273 | 22.50M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.41B | -2.31% | 1,002,454 | 62.38M |
| 68 | ERAS | Erasca, Inc. | 3.30B | 6.41% | 3,700,714 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.26B | -0.46% | 1,185,074 | 236.00M |
| 70 | ALMS | Alumis Inc. | 3.25B | -2.26% | 311,194 | 24.05M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.20B | 6.66% | 1,239,227 | - |
| 72 | KLRA | Kailera Therapeutics, Inc. | 3.19B | 1.40% | 382,527 | - |
| 73 | BEAM | Beam Therapeutics Inc. | 3.17B | 9.45% | 1,214,043 | 139.74M |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.11B | 7.84% | 1,080,656 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.98B | 1.71% | 644,662 | 376.07M |
| 76 | GPCR | Structure Therapeutics Inc. | 2.94B | 0.61% | 596,025 | - |
| 77 | NKTR | Nektar Therapeutics | 2.88B | 1.31% | 412,181 | 55.23M |
| 78 | KOD | Kodiak Sciences Inc. | 2.84B | 7.17% | 190,408 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | 1.23% | 505,182 | 451.36M |
| 80 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.02% | 1,372,915 | 190.41M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.69B | 1.39% | 330,833 | 1.55M |
| 82 | IMNM | Immunome, Inc. | 2.66B | 1.60% | 427,069 | 6.94M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.61B | 5.36% | 443,109 | - |
| 84 | IRON | Disc Medicine, Inc. | 2.60B | 0.55% | 149,714 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | 4.22% | 2,515,937 | 670.00M |
| 86 | DFTX | Definium Therapeutics, Inc. | 2.54B | 3.93% | 1,032,853 | - |
| 87 | IDYA | IDEAYA Biosciences, Inc. | 2.50B | -1.08% | 512,391 | 225.27M |
| 88 | ELVN | Enliven Therapeutics, Inc. | 2.49B | -1.56% | 197,135 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.49B | 3.19% | 607,401 | - |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.44B | 6.20% | 3,110,297 | 2.20B |
| 91 | RLAY | Relay Therapeutics, Inc. | 2.43B | -2.31% | 2,202,721 | 10.68M |
| 92 | ZLAB | Zai Lab Limited | 2.39B | 1.29% | 734,414 | 460.16M |
| 93 | ADMA | ADMA Biologics, Inc. | 2.37B | -0.59% | 5,494,492 | 510.17M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.12B | 0.15% | 1,971,933 | 52.04M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 1.12% | 510,972 | 283.06M |
| 96 | STOK | Stoke Therapeutics, Inc. | 2.07B | 0.88% | 292,346 | 184.42M |
| 97 | ZYME | Zymeworks Inc. | 2.03B | 3.11% | 282,913 | 105.97M |
| 98 | TYRA | Tyra Biosciences, Inc. | 2.02B | 0.15% | 244,496 | - |
| 99 | GENB | Generate Biomedicines, Inc. | 2.00B | 1.69% | 125,174 | 31.89M |
| 100 | TSHA | Taysha Gene Therapies, Inc. | 1.99B | - | 3,084,801 | 7.47M |
| 101 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -4.30% | 1,101,347 | - |
| 102 | ANAB | AnaptysBio, Inc. | 1.99B | -0.11% | 413,584 | 234.60M |
| 103 | AAPG | Ascentage Pharma Group International | 1.99B | -1.58% | 4,781 | 82.08M |
| 104 | INBX | Inhibrx Biosciences, Inc. | 1.98B | 5.99% | 571,901 | 1.30M |
| 105 | NBTX | Nanobiotix S.A. | 1.98B | 20.89% | 118,060 | 38.27M |
| 106 | CAPR | Capricor Therapeutics, Inc. | 1.97B | 3.25% | 482,504 | 11.13M |
| 107 | PHVS | Pharvaris N.V. | 1.97B | 0.10% | 207,917 | - |
| 108 | MESO | Mesoblast Limited | 1.96B | -0.19% | 123,785 | 65.38M |
| 109 | SION | Sionna Therapeutics, Inc. | 1.93B | 4.15% | 190,748 | - |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.92B | 3.16% | 2,722,614 | 67.67M |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.89B | 0.87% | 467,550 | 868.45M |
| 112 | GLPG | Galapagos NV | 1.88B | 1.78% | 59,088 | 1.31B |
| 113 | VCEL | Vericel Corporation | 1.87B | -0.03% | 376,916 | 276.26M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -0.02% | 178,205 | - |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | 2.29% | 1,115,312 | 217.17M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | 1.04% | 14,575,887 | 66.41M |
| 117 | VRDN | Viridian Therapeutics, Inc. | 1.79B | -7.36% | 4,556,760 | 70.92M |
| 118 | RAPP | Rapport Therapeutics, Inc. | 1.77B | 3.93% | 124,497 | - |
| 119 | ARDX | Ardelyx, Inc. | 1.75B | -0.70% | 3,381,569 | 427.68M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.74B | 1.51% | 600,663 | 71.78M |
| 121 | OCS | Oculis Holding AG | 1.74B | 6.05% | 178,482 | 1.51M |
| 122 | NUVB | Nuvation Bio Inc. | 1.72B | 2.28% | 4,628,954 | 143.05M |
| 123 | IOVA | Iovance Biotherapeutics, Inc. | 1.68B | 2.64% | 12,182,433 | 263.50M |
| 124 | INVA | Innoviva, Inc. | 1.68B | 0.09% | 356,199 | 411.33M |
| 125 | VIR | Vir Biotechnology, Inc. | 1.66B | 2.55% | 820,063 | 68.56M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | 6.10% | 774,789 | 123.67M |
| 127 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -1.95% | 672,414 | 66.05M |
| 128 | IMCR | Immunocore Holdings plc | 1.58B | 7.91% | 192,725 | 412.81M |
| 129 | NVAX | Novavax, Inc. | 1.56B | 17.41% | 13,274,592 | 596.34M |
| 130 | PGEN | Precigen, Inc. | 1.55B | 1.15% | 2,758,561 | 9.68M |
| 131 | IMTX | Immatics N.V. | 1.54B | 4.93% | 552,406 | 56.67M |
| 132 | ATAI | AtaiBeckley Inc. | 1.54B | 4.88% | 2,885,710 | 4.09M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.53B | 0.52% | 171,119 | - |
| 134 | BHVN | Biohaven Ltd. | 1.52B | 4.12% | 1,438,396 | - |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.52B | 1.33% | 62,143 | - |
| 136 | ABCL | AbCellera Biologics Inc. | 1.49B | 5.26% | 5,498,592 | 75.13M |
| 137 | MBX | MBX Biosciences, Inc. | 1.48B | 5.24% | 243,831 | - |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.47B | 0.34% | 208,372 | 2.50M |
| 139 | FTRE | Fortrea Holdings Inc. | 1.45B | 5.64% | 1,699,370 | 2.71B |
| 140 | QURE | uniQure N.V. | 1.45B | 8.60% | 2,445,697 | 18.09M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.39B | 0.91% | 2,672,942 | 71.80M |
| 142 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.17% | 5,079,195 | 73.62M |
| 143 | GHRS | GH Research PLC | 1.37B | 3.62% | 241,139 | - |
| 144 | SVRA | Savara Inc. | 1.34B | 0.38% | 623,388 | - |
| 145 | URGN | UroGen Pharma Ltd. | 1.33B | 14.65% | 2,069,520 | 140.49M |
| 146 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | 4.00% | 273,853 | - |
| 147 | MPLT | MapLight Therapeutics, Inc. | 1.33B | 4.76% | 163,975 | - |
| 148 | CRVS | Corvus Pharmaceuticals, Inc. | 1.32B | -0.38% | 492,739 | - |
| 149 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -1.04% | 227,630 | - |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.28B | 4.64% | 370,503 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.25B | 0.18% | 494,338 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.24B | 0.77% | 214,521 | 10.00M |
| 153 | DBVT | DBV Technologies S.A. | 1.20B | 2.72% | 240,396 | 5.74M |
| 154 | PHAR | Pharming Group N.V. | 1.16B | - | 2,744 | 376.13M |
| 155 | MNKD | MannKind Corporation | 1.13B | 28.32% | 32,682,694 | 348.97M |
| 156 | AVLN | Avalyn Pharma Inc. | 1.13B | -1.31% | 564,593 | - |
| 157 | AKTS | Aktis Oncology, Inc. | 1.11B | 3.65% | 100,759 | 6.50M |
| 158 | IVA | Inventiva S.A. | 1.11B | 0.18% | 43,705 | 7.94M |
| 159 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | - | 313,708 | - |
| 160 | XERS | Xeris Biopharma Holdings, Inc. | 1.10B | 2.57% | 1,365,010 | 291.85M |
| 161 | SEPN | Septerna, Inc. | 1.10B | 1.28% | 146,906 | 45.95M |
| 162 | EYPT | EyePoint, Inc. | 1.09B | -5.13% | 867,295 | 7.61M |
| 163 | OMER | Omeros Corporation | 1.07B | 0.20% | 356,873 | - |
| 164 | GERN | Geron Corporation | 1.03B | -2.73% | 16,057,826 | 196.12M |
| 165 | SANA | Sana Biotechnology, Inc. | 1.01B | 4.30% | 2,043,919 | - |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 999.23M | -0.12% | 514,616 | 204.89M |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 996.58M | 0.26% | 2,920,315 | 185.74M |
| 168 | XNCR | Xencor, Inc. | 973.29M | 2.18% | 447,029 | 125.58M |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 954.43M | -3.66% | 775,869 | - |
| 170 | SLS | SELLAS Life Sciences Group, Inc. | 952.19M | 5.95% | 2,579,232 | - |
| 171 | ABSI | Absci Corporation | 942.79M | 8.11% | 5,575,148 | 2.80M |
| 172 | SPRY | ARS Pharmaceuticals, Inc. | 942.33M | 5.09% | 1,878,803 | 84.28M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 927.92M | 1.07% | 335,144 | - |
| 174 | LBRX | LB Pharmaceuticals Inc | 925.22M | -1.87% | 148,730 | - |
| 175 | ANNX | Annexon, Inc. | 924.67M | -0.52% | 856,593 | - |
| 176 | MGTX | MeiraGTx Holdings plc | 921.87M | 2.15% | 351,715 | 81.39M |
| 177 | CTMX | CytomX Therapeutics, Inc. | 909.96M | 2.45% | 1,596,722 | 76.20M |
| 178 | JANX | Janux Therapeutics, Inc. | 888.75M | 1.95% | 613,588 | 10.00M |
| 179 | DSGN | Design Therapeutics, Inc. | 878.46M | 4.88% | 580,721 | - |
| 180 | TBPH | Theravance Biopharma, Inc. | 875.89M | 1.67% | 177,053 | 107.46M |
| 181 | ABUS | Arbutus Biopharma Corporation | 871.46M | 0.57% | 602,113 | 14.08M |
| 182 | ANRO | Alto Neuroscience, Inc. | 871.41M | -2.32% | 228,209 | - |
| 183 | VOR | Vor Biopharma Inc. | 855.59M | 1.74% | 409,008 | - |
| 184 | EVMN | Evommune, Inc. | 850.39M | -2.28% | 339,850 | 13.00M |
| 185 | KURA | Kura Oncology, Inc. | 843.25M | 2.26% | 677,146 | 67.48M |
| 186 | SGP | SpyGlass Pharma, Inc. | 841.01M | 3.07% | 136,562 | - |
| 187 | SPTX | Seaport Therapeutics, Inc. | 832.27M | -1.91% | 350,155 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 827.43M | 3.21% | 114,199 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 817.60M | 6.05% | 588,168 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 798.03M | 6.91% | 5,287,414 | 22.00K |
| 191 | GYRE | Gyre Therapeutics, Inc. | 779.83M | 3.34% | 97,153 | 116.59M |
| 192 | TRAX | First Tracks Biotherapeutics, Inc. | 730.25M | -0.83% | 306,312 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 727.15M | -1.12% | 753,104 | - |
| 194 | SLDB | Solid Biosciences Inc. | 711.53M | 4.78% | 1,657,123 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 686.36M | -1.82% | 1,655,798 | 49.80M |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 677.08M | 2.30% | 97,574 | - |
| 197 | ARVN | Arvinas, Inc. | 675.43M | -0.47% | 427,894 | 262.60M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 675.03M | 3.79% | 341,939 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 660.61M | -0.42% | 610,816 | 7.83M |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 659.72M | 5.18% | 1,414,179 | 106.47M |
| 201 | FBRX | Forte Biosciences, Inc. | 653.81M | -2.13% | 56,546 | - |
| 202 | AGMB | AgomAb Therapeutics NV | 653.03M | 6.08% | 112,932 | - |
| 203 | CRMD | CorMedix Inc. | 634.48M | 4.66% | 830,259 | 311.71M |
| 204 | STRO | Sutro Biopharma, Inc. | 626.76M | 1.37% | 97,515 | 102.48M |
| 205 | ALT | Altimmune, Inc. | 621.44M | 4.58% | 3,114,980 | 41.00K |
| 206 | PRME | Prime Medicine, Inc. | 611.14M | 1.77% | 2,187,145 | 4.63M |
| 207 | PRTA | Prothena Corporation plc | 602.39M | - | 199,333 | 9.68M |
| 208 | PROK | ProKidney Corp. | 599.39M | 3.39% | 462,140 | 893.00K |
| 209 | TRDA | Entrada Therapeutics, Inc. | 597.73M | 3.87% | 299,671 | 25.42M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 593.71M | 5.05% | 1,422,958 | 170.16M |
| 211 | CLYM | Climb Bio, Inc. | 587.55M | 7.42% | 950,588 | - |
| 212 | ENGN | enGene Therapeutics Inc. | 587.50M | 11.15% | 290,926 | - |
| 213 | CABA | Cabaletta Bio, Inc. | 586.98M | -13.25% | 5,689,299 | - |
| 214 | AVTX | Avalo Therapeutics, Inc. | 572.22M | 31.73% | 19,241,948 | 59.00K |
| 215 | KYTX | Kyverna Therapeutics, Inc. | 572.01M | 2.61% | 398,428 | - |
| 216 | CBIO | Crescent Biopharma, Inc. | 569.55M | -5.20% | 112,893 | 11.88M |
| 217 | CTNM | Contineum Therapeutics, Inc. | 563.77M | 4.93% | 172,569 | - |
| 218 | TECX | Tectonic Therapeutic, Inc. | 562.53M | 1.65% | 104,124 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 560.88M | 0.78% | 111,935 | - |
| 220 | CADL | Candel Therapeutics, Inc. | 557.78M | -0.72% | 1,338,744 | - |
| 221 | ANL | Adlai Nortye Ltd. | 548.60M | -8.14% | 95,583 | 5.00M |
| 222 | IMMX | Immix Biopharma, Inc. | 544.96M | 7.53% | 930,249 | - |
| 223 | MDXG | MiMedx Group, Inc. | 542.16M | - | 867,516 | 389.42M |
| 224 | AURA | Aura Biosciences, Inc. | 532.86M | -6.74% | 535,651 | - |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 525.83M | 6.08% | 518,769 | 85.21M |
| 226 | VSTM | Verastem, Inc. | 521.79M | -0.34% | 964,129 | 30.91M |
| 227 | VALN | Valneva SE | 516.63M | 1.89% | 37,537 | 205.07M |
| 228 | RGNX | REGENXBIO Inc. | 515.40M | 8.30% | 835,232 | 170.44M |
| 229 | NGNE | Neurogene Inc. | 505.95M | 11.96% | 252,028 | 925.00K |
| 230 | STTK | Shattuck Labs, Inc. | 504.89M | 2.14% | 300,311 | 1.00M |
| 231 | ADCT | ADC Therapeutics SA | 503.68M | 5.32% | 1,573,165 | 79.18M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 499.75M | 6.42% | 531,435 | 12.14M |
| 233 | SGMT | Sagimet Biosciences Inc. | 498.95M | 4.66% | 1,093,344 | - |
| 234 | ASMB | Assembly Biosciences, Inc. | 498.23M | 6.09% | 105,497 | 72.30M |
| 235 | UPB | Upstream Bio, Inc. | 497.40M | 0.22% | 211,722 | 2.85M |
| 236 | XOMA | XOMA Royalty Corporation | 496.77M | 0.07% | 118,200 | 52.15M |
| 237 | OCGN | Ocugen, Inc. | 495.93M | -1.68% | 12,951,291 | 4.47M |
| 238 | LYEL | Lyell Immunopharma, Inc. | 494.42M | 2.76% | 24,109 | 36.00K |
| 239 | RIGL | Rigel Pharmaceuticals, Inc. | 489.17M | -5.77% | 623,034 | 299.77M |
| 240 | OVID | Ovid Therapeutics Inc. | 477.58M | -2.47% | 1,787,198 | 7.25M |
| 241 | FULC | Fulcrum Therapeutics, Inc. | 473.10M | 1.14% | 307,242 | 80.00M |
| 242 | ZURA | Zura Bio Limited | 469.66M | -4.44% | 1,033,317 | - |
| 243 | LXEO | Lexeo Therapeutics, Inc. | 465.27M | 5.37% | 334,339 | - |
| 244 | AUTL | Autolus Therapeutics plc | 457.77M | 4.88% | 1,954,805 | 75.39M |
| 245 | AVIR | Atea Pharmaceuticals, Inc. | 457.35M | 2.05% | 159,995 | - |
| 246 | VNDA | Vanda Pharmaceuticals Inc. | 447.40M | 0.68% | 1,299,069 | 216.11M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.33M | 3.16% | 156,973 | - |
| 248 | LRMR | Larimar Therapeutics, Inc. | 436.31M | 4.74% | 1,460,521 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 436.16M | 3.80% | 221,389 | 66.98M |
| 250 | NMRA | Neumora Therapeutics, Inc. | 432.97M | 3.04% | 1,179,715 | - |
| 251 | BNTC | Benitec Biopharma Inc. | 425.62M | 1.84% | 75,256 | - |
| 252 | MNPR | Monopar Therapeutics Inc. | 423.61M | 11.29% | 231,694 | - |
| 253 | IPSC | Century Therapeutics, Inc. | 422.93M | 2.40% | 570,733 | 109.16M |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 422.51M | 9.32% | 2,017,156 | - |
| 255 | IVVD | Invivyd, Inc. | 418.55M | 6.47% | 2,006,189 | 53.43M |
| 256 | PRTC | PureTech Health plc | 416.06M | 1.86% | 17,497 | 4.66M |
| 257 | NAGE | Niagen Bioscience, Inc. | 405.25M | 4.77% | 821,854 | 129.42M |
| 258 | VTVT | vTv Therapeutics Inc. | 399.28M | 1.18% | 12,902 | 17.00K |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 399.14M | 4.52% | 509,796 | 35.11M |
| 260 | PBYI | Puma Biotechnology, Inc. | 381.57M | 2.04% | 253,303 | 228.37M |
| 261 | IRD | Opus Genetics, Inc. | 377.72M | 1.73% | 441,907 | 14.20M |
| 262 | SRZN | Surrozen, Inc. | 376.76M | 0.49% | 70,823 | 3.48M |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 371.07M | 2.10% | 194,527 | - |
| 264 | YDES | YD Bio Limited | 365.23M | 0.85% | 2,808 | 510.36K |
| 265 | BCYC | Bicycle Therapeutics plc | 361.78M | 5.92% | 552,232 | 63.50M |
| 266 | LCTX | Lineage Cell Therapeutics, Inc. | 357.44M | -1.71% | 567,066 | 14.56M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 353.47M | 4.96% | 100,619 | - |
| 268 | CMPX | Compass Therapeutics, Inc. | 349.37M | -0.51% | 7,683,300 | 850.00K |
| 269 | SLN | Silence Therapeutics plc | 347.17M | 2.94% | 300,432 | 559.00K |
| 270 | ABEO | Abeona Therapeutics Inc. | 341.01M | 2.83% | 1,253,924 | 5.82M |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 339.20M | 3.11% | 458,009 | 1.00 |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 334.29M | -2.67% | 43,910 | 4.90M |
| 273 | IMRX | Immuneering Corporation | 333.19M | -3.56% | 851,556 | - |
| 274 | PALI | Palisade Bio, Inc. | 327.31M | -0.76% | 1,349,536 | - |
| 275 | RZLT | Rezolute, Inc. | 326.16M | -4.56% | 1,103,120 | - |
| 276 | GLSI | Greenwich LifeSciences, Inc. | 320.46M | 3.72% | 76,003 | - |
| 277 | NGEN | NervGen Pharma Corp. | 316.04M | 3.58% | 110,537 | - |
| 278 | AVXL | Anavex Life Sciences Corp. | 309.52M | -0.60% | 820,160 | - |
| 279 | ARTV | Artiva Biotherapeutics, Inc. | 308.22M | 17.64% | 248,793 | 251.00K |
| 280 | EDIT | Editas Medicine, Inc. | 307.43M | 3.29% | 1,035,919 | 38.69M |
| 281 | TARA | Protara Therapeutics, Inc. | 303.95M | 3.88% | 382,241 | - |
| 282 | LENZ | LENZ Therapeutics, Inc. | 302.88M | 6.50% | 887,829 | 19.09M |
| 283 | ACIU | AC Immune SA | 297.60M | -0.33% | 261,063 | 4.62M |
| 284 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.65M | 1.22% | 665,677 | 26.87M |
| 285 | ALEC | Alector, Inc. | 293.56M | 3.50% | 338,698 | 21.05M |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 289.81M | 0.93% | 1,481,368 | - |
| 287 | CCCC | C4 Therapeutics, Inc. | 287.86M | -0.67% | 1,030,268 | 35.95M |
| 288 | REPL | Replimune Group, Inc. | 280.75M | 18.47% | 5,883,667 | - |
| 289 | ALXO | ALX Oncology Holdings Inc. | 277.19M | 6.74% | 505,220 | - |
| 290 | FHTX | Foghorn Therapeutics Inc. | 275.70M | 1.22% | 43,784 | 30.91M |
| 291 | HELP | Cybin Inc. | 274.70M | 5.17% | 557,626 | - |
| 292 | CHRS | Coherus Oncology, Inc. | 274.51M | -0.56% | 973,439 | 42.17M |
| 293 | NERV | Minerva Neurosciences, Inc. | 270.51M | -1.28% | 55,459 | - |
| 294 | CLLS | Cellectis S.A. | 269.67M | 4.26% | 16,050 | 79.59M |
| 295 | FATE | Fate Therapeutics, Inc. | 263.96M | -3.81% | 5,126,080 | 6.65M |
| 296 | NVCT | Nuvectis Pharma, Inc. | 263.66M | 2.37% | 95,228 | - |
| 297 | NBP | NovaBridge Biosciences | 261.94M | -4.83% | 1,834,970 | - |
| 298 | CGEN | Compugen Ltd. | 258.13M | 0.37% | 324,775 | 72.76M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 257.80M | 7.85% | 313,196 | 82.03M |
| 300 | SABS | SAB Biotherapeutics, Inc. | 256.51M | -0.82% | 525,252 | 114.70K |
| 301 | ACHV | Achieve Life Sciences, Inc. | 255.02M | 5.04% | 1,080,216 | - |
| 302 | HRTX | Heron Therapeutics, Inc. | 250.89M | 8.13% | 3,512,600 | 154.90M |
| 303 | VYGR | Voyager Therapeutics, Inc. | 247.93M | 6.67% | 593,411 | 40.37M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 247.88M | 6.99% | 163,613 | 44.64M |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 243.57M | 12.18% | 248,355 | 1.78M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 243.46M | 5.59% | 1,179,189 | 1.55M |
| 307 | CDXS | Codexis, Inc. | 241.26M | -3.45% | 1,259,234 | 70.39M |
| 308 | OBIO | Orchestra BioMed Holdings, Inc. | 239.35M | 2.00% | 375,527 | 33.48M |
| 309 | NKTX | Nkarta, Inc. | 234.55M | 6.82% | 868,051 | - |
| 310 | ADAG | Adagene Inc. | 233.57M | -2.35% | 116,155 | 7.67M |
| 311 | KROS | Keros Therapeutics, Inc. | 233.30M | 0.17% | 210,049 | 244.06M |
| 312 | SLGL | Sol-Gel Technologies Ltd. | 231.48M | -4.01% | 14,624 | 19.39M |
| 313 | MDWD | MediWound Ltd. | 222.92M | -0.54% | 45,351 | 16.96M |
| 314 | HUMA | Humacyte, Inc. | 219.80M | 9.77% | 5,167,921 | 2.04M |
| 315 | CNTX | Context Therapeutics Inc. | 219.13M | -2.25% | 384,196 | - |
| 316 | CAMP | Camp4 Therapeutics Corporation | 211.34M | 2.26% | 19,087 | 3.50M |
| 317 | OABI | OmniAb, Inc. | 208.49M | 2.86% | 413,981 | 18.67M |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 207.11M | 8.00% | 707,114 | 13.11M |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 206.95M | -2.44% | 134,825 | 146.07M |
| 320 | RNA | Atrium Therapeutics, Inc. | 205.26M | 2.48% | 120,913 | 18.62M |
| 321 | UNCY | Unicycive Therapeutics, Inc. | 205.18M | 0.62% | 589,921 | - |
| 322 | ENLV | Enlivex Ltd. | 201.25M | 1.84% | 246,607 | - |
| 323 | WHWK | Whitehawk Therapeutics, Inc. | 196.34M | -1.19% | 99,122 | 7.15M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 195.10M | 3.09% | 495,182 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 193.65M | 0.74% | 270,150 | 45.07M |
| 326 | ELTX | Elicio Therapeutics, Inc. | 192.97M | -0.94% | 74,562 | - |
| 327 | KRRO | Korro Bio, Inc. | 192.89M | 6.23% | 63,649 | 6.39M |
| 328 | CRBU | Caribou Biosciences, Inc. | 191.60M | 1.04% | 779,886 | 11.16M |
| 329 | MGNX | MacroGenics, Inc. | 190.04M | -5.08% | 787,232 | 149.50M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 188.88M | 3.50% | 169,559 | - |
| 331 | ABOS | Acumen Pharmaceuticals, Inc. | 187.07M | 2.78% | 185,372 | - |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 182.43M | -0.31% | 276,954 | - |
| 333 | PLYX | Polaryx Therapeutics, Inc. | 180.43M | -16.06% | 315,305 | - |
| 334 | IFRX | InflaRx N.V. | 179.29M | 25.89% | 16,248,889 | 34.44K |
| 335 | PRQR | ProQR Therapeutics N.V. | 179.11M | 4.29% | 450,300 | 19.19M |
| 336 | TNYA | Tenaya Therapeutics, Inc. | 170.00M | 3.86% | 4,346,385 | - |
| 337 | ANTX | AN2 Therapeutics, Inc. | 166.84M | -1.17% | 138,713 | - |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 164.77M | 4.34% | 936,607 | 52.74M |
| 339 | BDTX | Black Diamond Therapeutics, Inc. | 163.85M | -0.35% | 780,794 | 70.00M |
| 340 | MOLN | Molecular Partners AG | 161.25M | -0.24% | 1,999 | 856.30K |
| 341 | HURA | TuHURA Biosciences, Inc. | 160.22M | 8.62% | 1,048,743 | - |
| 342 | OKUR | OnKure Therapeutics, Inc. | 159.97M | -12.39% | 151,038 | - |
| 343 | MENS | Jyong Biotech Ltd. | 159.96M | 0.49% | 25,695 | - |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 159.36M | -1.01% | 117,416 | 2.00M |
| 345 | SPRB | Spruce Biosciences, Inc. | 157.30M | -1.90% | 31,600 | 697.00K |
| 346 | KZIA | Kazia Therapeutics Limited | 154.61M | 0.59% | 117,077 | 1.27M |
| 347 | AGEN | Agenus Inc. | 150.14M | -6.24% | 1,166,223 | 114.20M |
| 348 | GALT | Galectin Therapeutics Inc. | 149.10M | 1.57% | 321,637 | - |
| 349 | SPRO | Spero Therapeutics, Inc. | 148.23M | 5.79% | 478,816 | 66.80M |
| 350 | PYXS | Pyxis Oncology, Inc. | 147.65M | 28.42% | 1,419,587 | 13.86M |
| 351 | IMUX | Immunic, Inc. | 145.79M | -4.96% | 382,679 | - |
| 352 | CNTB | Connect Biopharma Holdings Limited | 140.74M | 0.81% | 59,569 | 64.00K |
| 353 | VRCA | Verrica Pharmaceuticals Inc. | 139.49M | 13.41% | 346,826 | 35.58M |
| 354 | ALPS | Alps Group Inc | 138.36M | 0.27% | 39,473 | 3.74M |
| 355 | ACOG | Alpha Cognition Inc. | 136.96M | -1.41% | 7,639 | 10.22M |
| 356 | EQ | Equillium, Inc. | 136.57M | 4.35% | 149,170 | 4.39M |
| 357 | IPHA | Innate Pharma S.A. | 135.08M | 11.11% | 14,830 | 10.57M |
| 358 | PEPG | PepGen Inc. | 129.25M | -3.11% | 1,722,727 | - |
| 359 | EDSA | Edesa Biotech, Inc. | 127.78M | -6.96% | 330,759 | - |
| 360 | GNLX | Genelux Corporation | 126.46M | 2.89% | 175,836 | 8.00K |
| 361 | AARD | Aardvark Therapeutics, Inc. | 125.99M | 5.58% | 95,177 | - |
| 362 | NTHI | NeOnc Technologies Holdings, Inc. | 123.20M | -1.98% | 60,543 | 39.99K |
| 363 | CBUS | Cibus, Inc. | 122.05M | 3.90% | 282,685 | 3.64M |
| 364 | BMEA | Biomea Fusion, Inc. | 120.74M | 9.87% | 1,544,441 | - |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 118.41M | -2.83% | 82,121 | - |
| 366 | CRDF | Cardiff Oncology, Inc. | 115.55M | 4.97% | 846,912 | 593.00K |
| 367 | GUTS | Fractyl Health, Inc. | 114.72M | 4.21% | 923,602 | 3.00K |
| 368 | TTRX | Turn Therapeutics Inc. | 113.05M | 2.57% | 11,556 | - |
| 369 | CUE | Cue Biopharma, Inc. | 111.98M | -1.55% | 740,825 | 27.47M |
| 370 | CGTX | Cognition Therapeutics, Inc. | 110.35M | -0.40% | 728,417 | - |
| 371 | ONCY | Oncolytics Biotech Inc. | 110.30M | 3.80% | 1,083,117 | - |
| 372 | SEER | Seer, Inc. | 108.33M | 3.23% | 158,833 | 16.58M |
| 373 | KALA | KALA BIO, Inc. | 108.01M | 3.66% | 1,128,153 | - |
| 374 | VANI | Vivani Medical, Inc. | 106.70M | 0.84% | 160,692 | - |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 105.86M | 2.03% | 958,409 | - |
| 376 | ANIX | Anixa Biosciences, Inc. | 102.76M | 2.17% | 87,224 | - |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 102.01M | 9.21% | 2,215,839 | 65.34K |
| 378 | COYA | Coya Therapeutics, Inc. | 100.40M | 0.71% | 59,632 | 7.95M |
| 379 | NRXP | NRx Pharmaceuticals, Inc. | 100.10M | -0.33% | 883,123 | 1.23M |
| 380 | NRXS | NeurAxis, Inc. | 99.98M | - | 236,974 | 3.57M |
| 381 | ATYR | aTyr Pharma, Inc. | 99.52M | 20.52% | 3,210,129 | 190.00K |
| 382 | PMN | ProMIS Neurosciences, Inc. | 98.64M | -0.50% | 20,895 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 96.97M | 9.91% | 899,883 | 1.63M |
| 384 | ACET | Adicet Bio, Inc. | 94.16M | 2.94% | 77,355 | - |
| 385 | OKYO | OKYO Pharma Limited | 89.74M | 6.87% | 119,145 | - |
| 386 | EXOZ | eXoZymes, Inc. | 89.37M | 6.59% | 1,557 | -700.00 |
| 387 | LONA | LeonaBio, Inc. | 89.24M | -1.35% | 15,046 | - |
| 388 | PYPD | PolyPid Ltd. | 85.87M | - | 27,431 | - |
| 389 | CSBR | Champions Oncology, Inc. | 84.71M | 2.18% | 15,397 | 57.95M |
| 390 | PTHS | Pelthos Therapeutics Inc. | 83.89M | -1.77% | 16,631 | 16.80M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.73M | -0.72% | 821,167 | - |
| 392 | FBIO | Fortress Biotech, Inc. | 82.44M | 4.07% | 273,474 | 63.26M |
| 393 | ACRV | Acrivon Therapeutics, Inc. | 82.33M | 2.16% | 252,911 | - |
| 394 | GOSS | Gossamer Bio, Inc. | 82.14M | 4.17% | 3,681,101 | 48.47M |
| 395 | ANVS | Annovis Bio, Inc. | 81.50M | 3.96% | 512,080 | - |
| 396 | ICCC | ImmuCell Corporation | 81.15M | 0.90% | 35,477 | 27.64M |
| 397 | GANX | Gain Therapeutics, Inc. | 81.10M | 2.67% | 366,391 | - |
| 398 | QTTB | Q32 Bio Inc. | 79.73M | 6.03% | 281,312 | 53.74M |
| 399 | ATHE | Alterity Therapeutics Limited | 78.70M | 0.44% | 9,576 | 4.43M |
| 400 | XBIT | XBiotech Inc. | 77.90M | 0.20% | 16,363 | - |
| 401 | MCRB | Seres Therapeutics, Inc. | 77.73M | 7.60% | 84,675 | 1.15M |
| 402 | PLRX | Pliant Therapeutics, Inc. | 77.70M | 3.72% | 459,571 | - |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 77.50M | 6.08% | 169,897 | - |
| 404 | RLYB | Rallybio Corporation | 76.59M | 1.40% | 174,414 | 858.00K |
| 405 | ACTU | Actuate Therapeutics, Inc. | 74.22M | 1.95% | 75,424 | - |
| 406 | OSTX | OS Therapies Incorporated | 74.20M | 2.02% | 309,436 | - |
| 407 | TCRX | TScan Therapeutics, Inc. | 73.32M | 0.83% | 672,010 | 10.33M |
| 408 | MNOV | MediciNova, Inc. | 71.87M | 3.56% | 31,895 | 409.66K |
| 409 | FLNA | Filana Therapeutics, Inc. | 70.53M | 5.80% | 402,805 | - |
| 410 | IBO | Impact BioMedical Inc. | 69.10M | -0.33% | 32,574 | 32.00K |
| 411 | IMA | ImageneBio, Inc. | 67.67M | 3.77% | 14,784 | 800.00K |
| 412 | BYSI | BeyondSpring Inc. | 66.41M | 12.15% | 12,179 | 1.88M |
| 413 | IBIO | iBio, Inc. | 63.25M | 8.70% | 1,232,665 | 300.00K |
| 414 | HYFT | MindWalk Holdings Corp. | 62.83M | 1.20% | 40,243 | 20.70M |
| 415 | IMMP | Immutep Limited | 62.53M | -2.70% | 680,894 | 5.28M |
| 416 | CING | Cingulate Inc. | 61.86M | 6.83% | 287,632 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 59.16M | - | 369,364 | - |
| 418 | INKT | MiNK Therapeutics, Inc. | 57.43M | 0.21% | 10,029 | - |
| 419 | ENTX | Entera Bio Ltd. | 57.35M | 6.03% | 96,567 | 42.00K |
| 420 | ESLA | Estrella Immunopharma, Inc. | 55.89M | -6.86% | 45,047 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 54.52M | 0.55% | 114,718 | - |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 53.46M | 0.71% | 152,450 | 25.21M |
| 423 | TIL | Instil Bio, Inc. | 53.44M | 0.64% | 67,601 | - |
| 424 | DWTX | Dogwood Therapeutics, Inc. | 53.11M | 10.42% | 155,214 | - |
| 425 | RADX | Radiopharm Theranostics Limited | 51.30M | -6.75% | 57,093 | 10.86M |
| 426 | ATOS | Atossa Therapeutics, Inc. | 49.77M | 3.58% | 50,084 | - |
| 427 | NTRB | Nutriband Inc. | 48.62M | -1.96% | 12,529 | 2.04M |
| 428 | LIXT | Lixte Biotechnology Holdings, Inc. | 48.53M | -6.86% | 92,869 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 47.10M | 3.01% | 109,980 | - |
| 430 | XLO | Xilio Therapeutics, Inc. | 46.09M | 3.37% | 16,507 | 43.77M |
| 431 | DARE | Daré Bioscience, Inc. | 45.43M | -4.59% | 1,440,564 | 1.03M |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 43.75M | 7.99% | 151,818 | 120.77M |
| 433 | HYPD | Hyperion DeFi, Inc. | 42.15M | -20.77% | 2,329,537 | 813.46K |
| 434 | PSTV | Plus Therapeutics, Inc. | 41.86M | -1.93% | 156,290 | 5.21M |
| 435 | LITS | Lite Strategy, Inc. | 41.74M | 0.70% | 565,711 | - |
| 436 | MREO | Mereo BioPharma Group plc | 41.50M | -6.71% | 1,225,308 | 500.00K |
| 437 | INMB | INmune Bio Inc. | 40.41M | -1.30% | 368,541 | 50.00K |
| 438 | RNXT | RenovoRx, Inc. | 40.10M | -4.13% | 232,460 | 1.12M |
| 439 | ALGS | Aligos Therapeutics, Inc. | 39.42M | 0.31% | 139,724 | 2.19M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 38.66M | -1.59% | 129,727 | 90.00K |
| 441 | NXTC | NextCure, Inc. | 37.88M | 12.66% | 65,356 | - |
| 442 | GRCE | Grace Therapeutics, Inc. | 37.14M | 3.00% | 1,284,097 | - |
| 443 | EVAX | Evaxion A/S | 36.86M | 0.45% | 8,097 | 7.53M |
| 444 | SNSE | Sensei Biotherapeutics, Inc. | 36.07M | 4.06% | 19,812 | - |
| 445 | CRVO | CervoMed Inc. | 35.60M | 3.08% | 15,230 | 4.01M |
| 446 | VERU | Veru Inc. | 35.47M | - | 59,150 | 16.89M |
| 447 | BOLD | Boundless Bio, Inc. | 35.40M | 0.64% | 54,722 | - |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 34.34M | -0.81% | 28,020 | - |
| 449 | PTN | Palatin Technologies, Inc. | 34.11M | -3.05% | 45,178 | 8.96M |
| 450 | APLM | Apollomics, Inc. | 33.47M | -4.75% | 2,997 | 8.84M |
| 451 | PLUR | Pluri Inc. | 33.42M | 0.76% | 13,826 | 1.34M |
| 452 | HOWL | Werewolf Therapeutics, Inc. | 32.07M | -1.45% | 211,439 | 1.14M |
| 453 | RNTX | Rein Therapeutics Inc. | 31.96M | 11.76% | 3,199,152 | - |
| 454 | NNVC | NanoViricides, Inc. | 31.74M | 0.68% | 197,800 | - |
| 455 | QNTM | Quantum BioPharma Ltd. | 31.56M | -0.37% | 147,356 | - |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 31.42M | -6.43% | 418,332 | - |
| 457 | IGC | IGC Pharma, Inc. | 31.25M | -1.82% | 468,084 | 1.11M |
| 458 | SNTI | Senti Biosciences Holdings, Inc. | 30.75M | 3.50% | 94,358 | 22.00K |
| 459 | TVGN | Tevogen Bio Holdings Inc. | 30.25M | -1.43% | 6,514 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 29.84M | -3.15% | 174,763 | - |
| 461 | LSTA | Lisata Therapeutics, Inc. | 29.81M | 0.91% | 24,931 | 170.00K |
| 462 | BCTX | BriaCell Therapeutics Corp. | 29.24M | - | 191,062 | - |
| 463 | NEUP | Neuphoria Therapeutics Inc. | 29.19M | 0.37% | 23,821 | 14.99M |
| 464 | TPST | Tempest Therapeutics, Inc. | 28.83M | -6.51% | 224,213 | - |
| 465 | KYNB | Kyntra Bio, Inc. | 28.78M | 0.14% | 2,995 | 6.44M |
| 466 | DYAI | Dyadic International, Inc. | 28.05M | -0.03% | 8,854 | 3.09M |
| 467 | SER | Serina Therapeutics, Inc. | 27.26M | 1.67% | 36,373 | 130.00K |
| 468 | PLRZ | Polyrizon Ltd. | 27.25M | 2.97% | 6,550 | - |
| 469 | JSPR | Jasper Therapeutics, Inc. | 26.72M | -1.24% | 194,130 | - |
| 470 | CELU | Celularity Inc. | 26.59M | -3.24% | 23,465 | 26.55M |
| 471 | BRNS | Barinthus Biotherapeutics plc | 26.07M | -2.58% | 34,585 | 14.97M |
| 472 | ABVC | ABVC BioPharma, Inc. | 25.62M | 0.67% | 106,582 | 797.92K |
| 473 | LGVN | Longeveron Inc. | 25.62M | 2.21% | 335,037 | 1.20M |
| 474 | MRKR | Marker Therapeutics, Inc. | 24.68M | -1.99% | 60,718 | 3.55M |
| 475 | CRIS | Curis, Inc. | 24.59M | 7.86% | 168,487 | 9.44M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 24.13M | 1.48% | 202,478 | 789.00K |
| 477 | AEON | AEON Biopharma, Inc. | 23.61M | 0.86% | 54,896 | - |
| 478 | OTLK | Outlook Therapeutics, Inc. | 23.46M | -7.20% | 6,371,190 | 205.70K |
| 479 | LTRN | Lantern Pharma Inc. | 23.43M | -3.24% | 77,637 | - |
| 480 | ALLR | Allarity Therapeutics, Inc. | 23.35M | 7.86% | 445,918 | 320.00K |
| 481 | VYNE | VYNE Therapeutics Inc. | 22.33M | 0.59% | 155,259 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.56M | -0.50% | 9,447 | 500.00K |
| 483 | KTTA | Pasithea Therapeutics Corp. | 21.45M | 1.16% | 175,223 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 20.38M | 1.63% | 634,053 | - |
| 485 | LPCN | Lipocine Inc. | 19.66M | 5.15% | 122,372 | 1.98M |
| 486 | ICU | SeaStar Medical Holding Corporation | 19.49M | 10.41% | 144,654 | 1.23M |
| 487 | COCP | Cocrystal Pharma, Inc. | 19.44M | 2.19% | 96,258 | - |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 19.16M | -1.50% | 81,253 | - |
| 489 | OSRH | OSR Holdings, Inc. | 18.88M | 10.02% | 2,870,505 | 2.91M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 18.63M | 0.06% | 607,066 | 3.94M |
| 491 | TRAW | Traws Pharma, Inc. | 17.62M | 9.81% | 123,647 | 2.79M |
| 492 | TOVX | Theriva Biologics, Inc. | 16.93M | -2.95% | 1,967,590 | 300.00K |
| 493 | LEXX | Lexaria Bioscience Corp. | 16.88M | -1.73% | 140,405 | 368.00K |
| 494 | GNTA | Genenta Science S.p.A. | 16.04M | 1.48% | 111,577 | - |
| 495 | GRDX | GridAI Technologies Corp. | 16.00M | 5.31% | 41,830 | - |
| 496 | HIND | Vyome Holdings, Inc. | 15.72M | 8.21% | 27,652 | 319.71K |
| 497 | INAB | IN8bio, Inc. | 15.68M | -1.73% | 65,396 | - |
| 498 | NCEL | NewcelX Ltd. | 15.22M | -6.97% | 70,044 | - |
| 499 | CLRB | Cellectar Biosciences, Inc. | 15.09M | 11.95% | 1,672,295 | - |
| 500 | BLRX | BioLineRx Ltd. | 14.39M | 8.88% | 69,711 | 1.18M |